Researchers have discovered two vulnerabilities in the widely used Cursor AI-enabled integrated development environment (IDE) ...
Venice AI is already profitable, with annualized run-rate revenues of over $70 million, CEO Erik Voorhees said.
Human-derived organoids improved heart function in pigs with ischemic heart disease, laying the groundwork for their therapeutic potential in humans.